This possible positive feedback loop between NF-kB and MDM2, ultimately leading to tumor cell progression, should also be investigated in MM, as it offers therapeutic targeting opportunities, as described in the literature [25]. The gene discussed is MDM2; the disease is Miyoshi myopathy.